ABBV

AbbVie Inc.
—

Company Information

Company Name
AbbVie Inc.
CIK
CIK0001551152
Category
Large accelerated filer
Ticker: Exchange
ABBV: NYSE
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2834
SIC Description
Pharmaceutical Preparations
Ticker
ABBV

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
2026-08-14
Shares purchased (TTM)
0
Shares sold (TTM)
78,989
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
1,314,176,696
Shares outstanding
1,769,000,000
Ownership
74.29%
+4.55% Y/Y

Earnings Market Reaction

Filing date
2026-11-03
Price on filing date
—
1-month reaction
Pending
3-month reaction
Pending
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)

Balance Sheet

Values in millions ($)
Line item2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value10,7746,5699,3915,2295,6296,4675,1755,5247,25713,13018,06712,814
Short Term Investments---28420131282722
Accounts Receivable Net Current13,50913,82412,47912,58912,76912,63712,47710,91911,47211,72411,94911,155
Inventory Net5,3055,1275,0494,9514,9384,9604,5264,1814,4504,2184,2454,099
Prepaid Expense And Other Assets Current7,8928,1496,6106,2655,1615,1975,4964,9274,5784,7174,6084,932
Assets Current37,48033,66933,52929,06228,53929,26127,67525,58227,78533,81638,87133,002
Long Term Investments387266268268291310287279267272305304
Property Plant And Equipment Net5,9415,7965,6875,6285,4835,2835,2375,1345,1415,0234,9804,989
Intangible Assets Net Excluding Goodwill56,65249,13950,87352,64154,31557,03158,48960,06866,64660,24362,22555,610
Goodwill37,80035,51935,57035,64035,62635,63835,28534,95635,29533,38633,42632,293
Other Assets Noncurrent9,42010,72610,53610,7219,6449,6599,1929,1428,2889,1979,0678,513
Assets147,680135,115136,463133,960133,898137,182136,165135,161143,422141,937148,874134,711
Liabilities Current
Short Term Borrowings0002,4993,7905,5561,5930--30
Long Term Debt And Capital Lease Obligations Current8,6738,3418,3266,0561,9821,9663,7696,80412,57012,58610,1937,191
Accounts Payable And Accrued Liabilities Current34,42933,30133,77434,73433,61932,24531,04131,94530,49229,32931,32630,650
Liabilities Current43,10241,64242,10043,28939,39139,76736,40338,74943,06241,91541,52237,841
Long Term Debt And Capital Lease Obligations72,23062,48164,53258,94162,97162,95964,52760,34058,50958,04863,80552,194
Deferred Income Tax Liabilities Net2,2232,2772,3322,3892,4802,5542,5822,5792,7492,7262,7221,952
Other Liabilities Noncurrent34,66334,60334,11132,56931,65532,04031,19130,12933,03132,42732,77832,327
Stockholders Equity
Common Stock Value Outstanding181818181818181818181818
Treasury Stock Value-10,616-10,618-10,611-9,146-9,143-9,147-9,137-8,201-7,848-7,838-7,829-6,533
Additional Paid In Capital Common Stock23,37123,15622,96222,49522,29121,98721,80821,33321,16020,87920,65620,180
Retained Earnings Accumulated Deficit-16,190-17,333-17,872-15,493-14,234-11,503-9,527-7,900-4,964-3,768-2,384-1,000
Accumulated Other Comprehensive Income Loss Net Of Tax-1,166-1,158-1,153-1,144-1,574-1,538-1,742-1,925-2,334-2,513-2,454-2,305
Stockholders Equity-4,538-5,935-6,656-3,228-2,599-1831,4203,3256,0716,8218,04710,360
Minority Interest454744424345423939434037
Liabilities And Stockholders Equity147,680135,115136,463133,960133,898137,182136,165135,161143,422141,937148,874134,711
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized4,0004,0004,0004,0004,0004,0004,0004,0004,0004,0004,0004,000
Common Stock Shares Issued1,8451,8441,8441,8391,8381,8371,8371,8321,8311,8301,8301,823
Treasury Stock Common Shares777777717171716664646457

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

AbbVie Inc. (ABBV) — SEC Financial Statements & Analysis

AbbVie Inc. (ABBV) is a pharmaceutical preparations company, incorporated in DE. AbbVie Inc. trades on NYSE as: ABBV. AbbVie Inc. (ABBV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-11-03. Based on that filing, AbbVie Inc. carries a market cap of $459.93B, a P/E ratio of 44.45x, a P/B ratio of -101.35x, a P/S ratio of 6.97x, an enterprise value of $530.06B, and an EV/EBITDA multiple of 24.08x. On profitability, it posts a gross margin of 73.72%, an operating margin of 32.16%, a net margin of 15.67%, a Return on Equity (ROE) of -289.93%, a Return on Assets (ROA) of 7.35%, and a Return on Invested Capital (ROIC) of 26.66%. Per share, it reports EPS of $5.85, diluted EPS of $5.84, free cash flow per share of $10.67, and a dividend per share of $6.86. Over the trailing year, it posted revenue growth of 10.68% year-over-year, net income growth of 332.16% year-over-year, and EPS growth of 332.16% year-over-year. On the balance sheet, it maintains a current ratio of 0.87x, a quick ratio of 0.56x, working capital of $-5.62B, a debt-to-equity ratio of -9.50x, a debt ratio of 0.29, an interest coverage ratio of 7.93x, free cash flow of $18.87B (TTM), and net debt of $70.13B. Figures sourced from SEC EDGAR.

Market Cap
$459.93B
P/E TTM
44.45x
EPS TTM
$5.85
P/B TTM
-101.35x
ROE TTM
-289.93%
ROA TTM
7.35%
Debt To Equity
-9.50x
Free Cash Flow TTM
$18.87B
Net Revenue TTM Growth 1Y
10.68%

Data as of 2026-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AbbVie Inc. in?

AbbVie Inc. (ABBV) operates in the Pharmaceutical Preparations industry.

What exchange does ABBV trade on?

AbbVie Inc. (ABBV) trades on the NYSE.

Where is AbbVie Inc. incorporated?

AbbVie Inc. is incorporated in DE.

When was AbbVie Inc. (ABBV)'s most recent SEC filing?

AbbVie Inc. (ABBV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-11-03.

What is ABBV's market cap?

AbbVie Inc. (ABBV) has a market capitalization of $459.93B as of 2026-09-30.

What is ABBV's P/E ratio?

AbbVie Inc. (ABBV)'s trailing twelve month P/E ratio is 44.45x as of 2026-09-30.

What is ABBV's EPS (earnings per share)?

AbbVie Inc. (ABBV)'s trailing twelve month EPS is $5.85 as of 2026-09-30.

What is ABBV's ROE (return on equity)?

AbbVie Inc. (ABBV)'s trailing twelve month Return on Equity (ROE) is -289.93% as of 2026-09-30.

What is ABBV's ROA (return on assets)?

AbbVie Inc. (ABBV)'s trailing twelve month Return on Assets (ROA) is 7.35% as of 2026-09-30.

What is ABBV's ROIC (return on invested capital)?

AbbVie Inc. (ABBV)'s trailing twelve month Return on Invested Capital (ROIC) is 26.66% as of 2026-09-30.

What is ABBV's EV/EBITDA?

AbbVie Inc. (ABBV)'s trailing twelve month EV/EBITDA is 24.08x as of 2026-09-30.

Wall Street's data.
Main Street's price.